Skip to main content
Audrea Merchant, MD, Psychiatry, Oak Ridge, TN, Ridgeview Psychiatric Hospital and Center

AudreaMerchantMD

Psychiatry Oak Ridge, TN

Physician

Dr. Merchant is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Merchant's full profile

Already have an account?

Education & Training

  • Vidant Medical Center/East Carolina University
    Vidant Medical Center/East Carolina UniversityResidency, Internal Medicine/Psychiatry, 1999 - 2003
  • Vidant Medical Center/East Carolina University
    Vidant Medical Center/East Carolina UniversityInternship, Internal Medicine, 1998 - 1999
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1998
  • University of Michigan
    University of MichiganPhD, Pharmacology, Howard Hughes Graduate Research Fellowship, 1989 - 1995
  • University of Tampa
    University of TampaBS, Chemistry, Full academic scholarship, 1985 - 1989
  • University of Tampa
    University of TampaB.S., Major in Chemistry, Minor in Biology, Cum Laude, 1985 - 1989

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2012 - 2025
  • FL State Medical License
    FL State Medical License 2011 - 2022
  • NC State Medical License
    NC State Medical License 1998 - 2003

Awards, Honors, & Recognition

  • Graduated with Honors University of Tampa, 1989
  • Presidential Academic Scholars Award University of Tampa

Publications & Presentations

PubMed

Journal Articles

  • Prevention of Fluorodeoxyuridine-Induced Cytotoxicity and DNA Damage in HT29 Colon Carcinoma Cells by Conditional Expression of Wild-Type p53 Phenotype  
    L.A. Parsels, R.C. Zellars, T.L. Loney, J.D. Parcels, M.F. Clarke, A.K. Merchant, T.S. Lawrence, and J. Maybaum, Molecular Pharmacology, 1/1/1997
  • Expression of Wild-Type p53 Stimulates an Increase in Both Bax and Bcl-xL Protein content in HT29 Cells  
    A.K. Merchant, T.L. Loney, and J. Maybaum, Oncogene, 1/1/1997
  • Dependence of Fluorodeoxyuridine-induced Cytotoxicity and Megabase DNA Fragment Formation on S Phase Progression in HT29 Cells  
    H.Y. Tang, K.L. Weber, T.S. Lawrence, A.K. Merchant, and J. Maybaum, Cancer Chemotherapy Pharmacology, 1/1/1996
  • Join now to see all

Hospital Affiliations